Skip to main content

Table 1 SNX29 protein expression in various cancers

From: Pan-cancer analysis of the prognostic and immunological role of SNX29: a potential target for survival and immunotherapy

Tissue

Number of samples

High expression

Medium expression

Low expression

Not detected

Glioma

12

1

3

8

0

lymphoma

12

0

4

2

6

Prostate cancer

11

0

3

5

3

Thyroid cancer

4

0

1

3

0

Head and neck cancer

4

0

1

2

1

Breast cancer

12

0

2

6

3

Renal cancer

12

0

2

5

5

Endometrial cancer

12

0

2

7

3

Liver cancer

10

0

1

7

2

Ovarian cancer

10

0

1

6

3

Colorectal cancer

11

0

1

10

0

Urothelial cancer

11

0

1

5

5

Testis cancer

11

0

1

2

5

Melanoma

12

0

1

6

 

Lung cancer

10

0

0

8

2

Stomach cancer

9

0

0

3

6

Carcinoid

4

0

0

4

0

Pancreatic cancer

11

0

0

6

5

Cervical cancer

9

0

0

3

6

Skin cancer

11

0

0

7

4